Honeywell to Invest in Rhino Health USA to Increase Domestic Production of Nitrile Exam Gloves

Date Published07/08/2022
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Rhino Health, LLC
Parent companyHoneywell
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2022
City reshored to:Fort Worth
State(s) reshored to:TX
If relevant, work nearshored to:-
Industry(ies):Medical Equipment & Supplies
Product(s) reshoredPPE
What domestic positive factors made reshoring more attractive?Higher productivity, Image/brand, Impact on domestic economy, Lead time/Time to market, Proximity to customers/market, Other, supply chain
Find Reshoring Articles